All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 313–336 of 416 in Industry & Access

Apr 1, 2026longevity.technology

Anavex updates regulatory strategy for blarcamesine

landmarkIndustry & Access

Mar 31, 2026longevity.technology

Longevity biotech investment 2026: we’re set for a breakout year

generalIndustry & Access

Mar 31, 2026fiercebiotech.com

Obesity biotech Ambrosia scores $100M series B to take next-gen oral GLP-1 into the clinic

landmarkIndustry & Access

Mar 31, 2026fiercebiotech.com

Merck enlists antibody hunter Infinimmune for $838M biobucks pact

generalIndustry & Access

Mar 31, 2026nature.com

Single-cell spatial atlas of the aging human breast

generalIndustry & Access

Mar 31, 2026sciencedaily.com

This Viagra ingredient just did something remarkable for a deadly childhood disease

significantIndustry & Access

Mar 31, 2026fiercebiotech.com

Lipella files for bankruptcy, ending dream of developing mouth inflammation drug

significantIndustry & Access

Mar 31, 2026fiercebiotech.com

AstraZeneca’s Strensiq successor misses phase 3 rare disease goal, denting market expansion plan

landmarkIndustry & Access

Mar 31, 2026investor.lilly.com

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

significantIndustry & Access

Mar 31, 2026investor.lilly.com

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

significantIndustry & Access

Mar 31, 2026investor.lilly.com

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

generalIndustry & Access

Mar 31, 2026longevity.technology

Alterity receives positive FDA feedback on ATH434 Phase 3 program

landmarkIndustry & Access

Mar 31, 2026news.google.com

WHOOP lands $575M at $10.1bn valuation led by Collaborative Fund to scale healthspan platform - Tech Funding News

generalIndustry & Access

Mar 31, 2026sciencedaily.com

This new test could transform UTI treatment with same-day results

significantIndustry & Access

Mar 30, 2026fiercebiotech.com

Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community

significantIndustry & Access

Mar 30, 2026lifespan.io

How a Growth Factor and SIRT1 Might Combat Disc Degeneration

significantIndustry & Access

Mar 30, 2026fiercebiotech.com

J&J secures $500M Royalty backing for autoimmune antibody program

significantIndustry & Access

Mar 30, 2026fiercebiotech.com

Kevin Tang uses newfound control of Aurinia to finally take over Kezar

generalIndustry & Access

Mar 30, 2026longevity.technology

Global rallies call for aging to be treated

generalIndustry & Access

Mar 30, 2026fiercebiotech.com

Kailera plots IPO to fund obesity pipeline after one of the biggest raises of 2025

landmarkIndustry & Access

Mar 30, 2026fiercebiotech.com

Biogen’s litifilimab sparkles in midphase lupus trial, raising hopes for pivotal readout

landmarkIndustry & Access

Mar 30, 2026longevity.technology

Insilico, Tenacia expand AI-driven CNS collaboration

significantIndustry & Access

Mar 30, 2026longevity.technology

Scalable biotech manufacturing targets $14B cell therapy market

generalIndustry & Access

Mar 30, 2026sciencedaily.com

Powerful cholesterol drug cuts heart attack risk by 31%

significantIndustry & Access